Rosol Michael Stanley 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Sep 13, 2022
Insider Transaction Report
Form 4
Rosol Michael Stanley
Chief Medical Officer
Transactions
- Award
Common Stock
2022-09-09+28,150→ 42,725 total - Award
Common Stock
2022-09-09+13,000→ 55,725 total
Holdings
- 11,320(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]The Reporting Person elected to receive stock in lieu of a cash bonus. The number of shares was determined based on the closing price on the date of grant, September 9, 2022.
- [F2]Stock Issued under the Amended and Restated 2014 Stock Incentive Plan.